Regulus Therapeutics Inc (RGLS)
2.27
+0.01
(+0.44%)
USD |
NASDAQ |
May 31, 16:00
2.295
+0.02
(+1.10%)
After-Hours: 20:00
Regulus Therapeutics Price to Book Value: 1.381 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 1.381 |
| May 30, 2024 | 1.375 |
| May 29, 2024 | 1.296 |
| May 28, 2024 | 1.244 |
| May 24, 2024 | 1.229 |
| May 23, 2024 | 1.168 |
| May 22, 2024 | 1.168 |
| May 21, 2024 | 1.150 |
| May 20, 2024 | 1.223 |
| May 17, 2024 | 1.217 |
| May 16, 2024 | 1.217 |
| May 15, 2024 | 1.229 |
| May 14, 2024 | 1.266 |
| May 13, 2024 | 1.272 |
| May 10, 2024 | 1.345 |
| May 09, 2024 | 1.369 |
| May 08, 2024 | 1.381 |
| May 07, 2024 | 1.357 |
| May 06, 2024 | 1.479 |
| May 03, 2024 | 1.613 |
| May 02, 2024 | 1.637 |
| May 01, 2024 | 1.527 |
| April 30, 2024 | 1.400 |
| April 29, 2024 | 1.533 |
| April 26, 2024 | 1.473 |
| Date | Value |
|---|---|
| April 25, 2024 | 1.381 |
| April 24, 2024 | 1.351 |
| April 23, 2024 | 1.375 |
| April 22, 2024 | 1.339 |
| April 19, 2024 | 1.296 |
| April 18, 2024 | 1.351 |
| April 17, 2024 | 1.424 |
| April 16, 2024 | 1.558 |
| April 15, 2024 | 1.692 |
| April 12, 2024 | 1.704 |
| April 11, 2024 | 1.692 |
| April 10, 2024 | 1.594 |
| April 09, 2024 | 1.643 |
| April 08, 2024 | 1.625 |
| April 05, 2024 | 1.546 |
| April 04, 2024 | 1.533 |
| April 03, 2024 | 1.588 |
| April 02, 2024 | 1.655 |
| April 01, 2024 | 1.704 |
| March 28, 2024 | 8.901 |
| March 27, 2024 | 8.901 |
| March 26, 2024 | 8.793 |
| March 25, 2024 | 8.716 |
| March 22, 2024 | 8.298 |
| March 21, 2024 | 8.592 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4012
Minimum
Mar 27 2023
12.17
Maximum
Dec 22 2020
1.782
Average
1.165
Median
Jan 18 2024
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals Inc | 5.369 |
| Cassava Sciences Inc | 13.46 |
| Vertex Pharmaceuticals Inc | 6.336 |
| Cormedix Inc | 4.993 |
| Oragenics Inc | 8.766 |
Price to Book Value Related Metrics
| Price | 2.27 |
| Earnings Yield | -63.88% |
| Market Cap | 148.61M |